CIK 0001604464 · Non-accelerated filer<br>Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460920988
- Phone
- 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 4 Shares withheld for taxes 10% owner gave up 5 shares (to pay taxes)
- S-3 Offering Registration Statement
- 424B5 Offering Prospectus
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Other events
- 4 Grant or award President and CEO acquired 81,100 shares (grant or award)
- 4 Grant or award Chief Accounting Officer acquired 20,300 shares (grant or award)
- 4 Open-market sale Chief Accounting Officer sold 2,104 shares at an average $5.08 ($10,691)
- 4 Open-market sale President and CEO sold 2,996 shares at an average $5.09 ($15,237)
- 8-K Event Other events
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Material agreement · Unregistered share sale · Other events
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale 10% owner sold 80,554 shares at $6.07 ($489,019)
Page 3 of 57 · 1,133 filings